Merit Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
14,776
+3,983
| +37% | +$312K | 0.01% | 722 |
|
|
2025
Q1 | $782K | Buy |
10,793
+5,212
| +93% | +$378K | 0.01% | 752 |
|
|
2024
Q4 | $413K | Buy |
5,581
+1,316
| +31% | +$97.4K | 0.01% | 788 |
|
|
2024
Q3 | $281K | Sell |
4,265
-423
| -9% | -$27.9K | 0.01% | 686 |
|
|
2024
Q2 | $433K | Buy |
4,688
+22
| +0.5% | +$2.03K | 0.01% | 616 |
|
|
2024
Q1 | $398K | Buy |
4,666
+634
| +16% | +$54K | 0.01% | 615 |
|
|
2023
Q4 | $307K | Sell |
4,032
-2,049
| -34% | -$156K | 0.01% | 614 |
|
|
2023
Q3 | $421K | Sell |
6,081
-387
| -6% | -$26.8K | 0.01% | 489 |
|
|
2023
Q2 | $610K | Buy |
6,468
+447
| +7% | +$42.2K | 0.02% | 418 |
|
|
2023
Q1 | $498K | Sell |
6,021
-639
| -10% | -$52.9K | 0.02% | 395 |
|
|
2022
Q4 | $497K | Buy |
6,660
+3,531
| +113% | +$263K | 0.02% | 422 |
|
|
2022
Q3 | $259K | Buy |
3,129
+898
| +40% | +$74.3K | 0.01% | 468 |
|
|
2022
Q2 | $212K | Buy |
+2,231
| New | +$212K | 0.01% | 498 |
|